Certified by Founder Lodge
Reprieve Cardiovascular
United States - Milford, Massachusetts
START UP
1 Disclosed Funding Rounds $42,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 21 ,2024 | Series A | $42,000,000 | |
| August, 28 ,2025 | Series B | $61,000,000.00 |
Lightstone Ventures
SANTÉ
Arboretum Ventures
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
